HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plant adaptogens. II. Bryonia as an adaptogen.

Abstract
Bryonia, a well-known medicinal plant used mainly in homeopathy as an antiinflammatory, has never been considered an adaptogen. However, much evidence has been accumulated during the last decade indicating that Bryonia roots have adaptogenic properties. This review summarizes the reports (published mainly in Russian) on the chemical composition, the pharmacological and biochemical investigations of the active principles of Bryonia alba roots. It also summarizes reports on clinical trials of a Bryonia extract (tablets prepared from a standardized powder of Bryonia alba root, called "Loshtak" in Armenia) that indicates it is an adaptogenic and restorative drug with immunomodulatory, stress-protective and tonic properties that increase the nonspecific resistance of an organism toward harmful stimuli. The major active components of the Bryonia extract are cucurbitacin glucosides and trihydroxyoctadecadienoic acids (THODA). The biological activities of these compounds are associated with biosynthesis of eicosanoids and corticosteroids, which are important mediators in the immune, endocrine and nervous systems. Clinical trials show that the Bryonia extract was effective in treating workers at the Chernobyl Nuclear reactor who suffered from vegetovessel dystonia and other accompanying illnesses as a result of that facility's well-known accident. It was also effective in preventing radiation-induced disorders and cytostatic side effects in cancer therapy. The use of Bryonia extract in healthy athletes increases their endurance, working capacity and heart rate restoration after physical loading. No side effects caused by Bryonia extract intake were recorded during these trials.
AuthorsA Panossian, E Gabrielian, H Wagner
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 4 Issue 1 Pg. 85-99 (Mar 1997) ISSN: 0944-7113 [Print] Germany
PMID23195251 (Publication Type: Journal Article)
CopyrightCopyright © 1997 Gustav Fischer Verlag. Published by Elsevier GmbH.. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: